What are the non‑ischemic causes of a left ventricular apical aneurysm and how should it be worked up?

Non-Ischemic Causes of Left Ventricular Apical Aneurysm

The most important non-ischemic causes of LV apical aneurysm are hypertrophic cardiomyopathy (particularly the apical variant), cardiac sarcoidosis, post-cardiac surgery complications (especially after apical venting), congenital aneurysms, and supravalvular aortic stenosis. 1

Primary Non-Ischemic Etiologies

Hypertrophic Cardiomyopathy (Most Common Non-Ischemic Cause)

• Apical aneurysms occur in 2-5% of HCM patients and represent a high-risk phenotype 2, 3
• The mechanism involves high systolic intra-aneurysmal pressure combined with impaired diastolic perfusion, leading to supply-demand ischemia and myocardial injury even without coronary disease 2
• 95% of HCM patients with apical aneurysms have associated mid-LV obstruction with complete systolic emptying 4
• Larger papillary muscles and greater systolic area changes contribute to obstruction 4

Cardiac Sarcoidosis

• Can present with LV apical aneurysm as a manifestation of granulomatous infiltration 5
• Echocardiography shows ventricular septal thickening and diastolic dysfunction in acute phase, but thinning in chronic phase with associated regional wall motion abnormalities and aneurysm formation 1
• Apical thickening may also be seen in endomyocardial fibrosis 1

Post-Cardiac Surgery

• 62% of postoperative LV apical aneurysms are true aneurysms, 38% are pseudoaneurysms 6
• Nearly all cases occur after cardiac surgery under cardiopulmonary bypass with apical venting 6
• This is a critical iatrogenic cause to recognize in patients with prior cardiac operations

Congenital Apical Aneurysm

• Rare isolated anomaly, distinct from congenital LV diverticulum 7
• Usually diagnosed by exclusion and presents with progressive heart failure symptoms 7

Supravalvular Aortic Stenosis

• Diffuse type SVAS can lead to LV apical aneurysm through chronic pressure overload and subtle myocardial ischemia 8

Other Infiltrative/Restrictive Causes

• Endomyocardial fibrosis can cause apical thickening and aneurysm formation 1
• Various restrictive cardiomyopathies may present with apical involvement 1

Diagnostic Workup Algorithm

Initial Imaging: Transthoracic Echocardiography

• First-line test for identifying and characterizing the aneurysm 1
• Assess for:
  • Aneurysm size, location, and morphology (dyskinesis vs akinesis)
  • Presence of thrombus within the aneurysm
  • LV wall thickness patterns (asymmetric septal hypertrophy, apical hypertrophy)
  • Mid-LV obstruction (look for midsystolic Doppler signal void indicating complete flow cessation) 4
  • Diastolic function parameters
  • Regional wall motion abnormalities
  • Papillary muscle size and position 4
• Contrast echocardiography is useful for evaluating apical lesions, thrombus, and noncompaction 1
• Speckle-tracking strain imaging: relative apical sparing pattern (ratio ≥1.0) suggests cardiac amyloidosis 1

Advanced Imaging: Cardiac MRI (Essential for Tissue Characterization)

• CMR is critical for definitive diagnosis and risk stratification 1, 9
• Provides:
  • Precise aneurysm size measurement (critical as size ≥2 cm confers significantly worse prognosis) 3
  • Late gadolinium enhancement (LGE) patterns to distinguish etiologies:
    • HCM: LGE brightest and most transmural at or apical to the level of complete emptying 4
    • Sarcoidosis: patchy mid-wall or subepicardial enhancement in basal and mid segments 1
    • Non-ischemic pattern: mid-wall or subepicardial (vs subendocardial in ischemic)
  • Native T1 mapping for detecting diffuse interstitial fibrosis 9
  • Thrombus detection (no contrast uptake on early or late enhancement) 9
  • Extracellular volume quantification 1

Coronary Evaluation

• Coronary CTA or invasive angiography to definitively exclude ischemic etiology 1
• Even with "normal" coronaries, consider coronary embolization in HCM patients with apical aneurysm 10

Endomyocardial Biopsy (Selective Cases)

• Indicated when sarcoidosis is suspected to demonstrate noncaseating granulomas with giant cells 5
• Consider for unexplained restrictive patterns or when infiltrative disease is suspected 1

Nuclear Medicine (Etiology-Specific)

• For suspected sarcoidosis: FDG-PET, Gallium-67, or thallium-201 1
• For suspected amyloidosis: Tc-99m-PYP, Tc-99m-DPD, or other amyloid tracers 1

Genetic Testing

• Essential in HCM patients given familial inheritance patterns 1
• Consider in young patients with dilated cardiomyopathy or unexplained aneurysms 1

Critical Clinical Pitfalls

Risk Stratification in HCM with Apical Aneurysm

• Aneurysm size ≥2 cm is a critical threshold: 5-year SCD rate of 9.7% vs 2.9% for smaller aneurysms 3
• Annualized event rates for aneurysms ≥2 cm:
  • SCD/appropriate ICD therapy: 1.77%/year
  • Stroke or thrombus: 2.7%/year (HR 2.20) 3
  • LV dysfunction (EF <50%): 1.28%/year 3
• Each 1-cm increase in aneurysm size increases risk: HR 1.69 for SCD, HR 1.60 for stroke/thrombus, HR 1.63 for LV dysfunction 3

Thrombus Formation

• Can occur even without apical aneurysm, impaired LV function, or arrhythmia in HCM 9
• Regional fibrosis and altered apical flow dynamics contribute to thrombus formation even in hypercontractile ventricles 9
• Multimodal imaging essential for accurate thrombus detection 9

Mid-LV Obstruction Recognition

• Only 19% of HCM patients with mid-LV obstruction have Doppler gradients ≥30 mmHg 4
• Look for midsystolic Doppler signal void (84% sensitive) indicating complete flow cessation rather than relying solely on gradient measurements 4

Post-Surgical Aneurysms

• High index of suspicion in any patient with prior cardiac surgery involving apical venting 6
• Distinguish true aneurysm from pseudoaneurysm as management differs 6

Differential Diagnosis Considerations

• Takotsubo cardiomyopathy (transient, stress-related, reversible) 6
• Post-transapical TAVR complications 6
• LV diverticulum (congenital, contains all myocardial layers, typically benign) 6, 7